PMID: 8952219Sep 1, 1996Paper

Update of the epidemiology of Kawasaki disease in Japan--from the results of 1993-94 nationwide survey

Journal of Epidemiology
H YanagawaT Kawasaki

Abstract

The objective of this article is to describe the epidemiologic pictures of Kawasaki disease(KD) in Japan during the 2-year period of 1993 and 1994 based on the data obtained by the thirteenth nationwide epidemiologic survey of KD which was conducted by the Japan Kawasaki Disease Research Committee. A survey form and diagnostic criteria of KD were sent to all hospital pediatric departments (2,640) throughout Japan with 100 or more beds. The patients to be reported in this surveys were all the incident KD cases who satisfied the diagnostic criteria. (1) A total of 1,730 (65.5%) hospitals responded, reporting 11,458(5,389 in 1993 and 6,069 in 1994; 6,729 males and 4,729 females; male/female ratio = 1.42) with an incidence rate of 95.1 per 100,000 children of age < 5 years. (2) The monthly number of patients was higher in winter and summer, although the monthly difference was not marked. (3) Age specific incidence rates showed a uni-modal peak at one year of age. (4) The proportion of patients with family history of KD in sibling was 1%. (5) The proportion of recurrent patients was 3%. (6) The proportion of patients with cardiac sequelae in one month after disease onset was 13%. (7) Number of fatal patients reported was 9, which co...Continue Reading

Citations

Apr 28, 1999·Pediatric Clinics of North America·A H Rowley, S T Shulman
Dec 21, 2000·Clinical and Experimental Immunology·T Asano, S Ogawa
Feb 10, 1999·The Pediatric Infectious Disease Journal·H YanagawaI Oki
Feb 13, 2002·The Pediatric Infectious Disease Journal·Zhong-Dong DuHiroshi Yanagawa
May 14, 1998·Archives of Disease in Childhood·Y NakamuraH Kato
Dec 22, 2005·Journal of Epidemiology·Guo-Ying HuangTomisaku Kawasaki
Jul 19, 2008·Journal of Epidemiology·Yosikazu NakamuraHiroshi Yanagawa
Jun 10, 2010·Journal of Epidemiology·Yosikazu NakamuraHiroshi Yanagawa
Aug 13, 2003·Pediatrics International : Official Journal of the Japan Pediatric Society·Yosikazu NakamuraHiroshi Yanagawa
Sep 21, 2004·Clinical Pediatrics·Raja Mouallem, Arturo S Gastañaduy
Jan 24, 2018·Pediatrics International : Official Journal of the Japan Pediatric Society·Yasuhiko TomitaTakashi Fukaya
May 2, 2002·Pediatrics International : Official Journal of the Japan Pediatric Society·Yosikazu NakamuraHiroshi Yanagawa
Nov 3, 2017·Pediatrics International : Official Journal of the Japan Pediatric Society·Yosikazu NakamuraKazuhiko Kotani
Nov 20, 1998·Acta Paediatrica Japonica; Overseas Edition·Y NakamuraT Kawasaki
May 22, 2010·Pediatrics International : Official Journal of the Japan Pediatric Society·Daisuke SudoYosikazu Nakamura
Sep 18, 2013·Journal of Epidemiology·Yosikazu NakamuraHiroshi Yanagawa
Feb 6, 2020·Current Rheumatology Reports·Priya R SoniMoshe Arditi
Nov 16, 2017·The Pediatric Infectious Disease Journal·Joseph Y AbramsYosikazu Nakamura
Apr 25, 2014·Journal of Medical Virology·Kazuya ShiratoFumihiro Taguchi
Jun 9, 2016·PloS One·John C WhitinHarvey J Cohen
Sep 1, 2017·Circulation Journal : Official Journal of the Japanese Circulation Society·Ryuji FukazawaShunichi Ogawa
Aug 31, 2020·Annals of Pediatric Cardiology·Rachel K CasonMary C Niu
Dec 27, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Yosikazu NakamuraHiroshi Yanagawa
Dec 1, 2015·Indian Journal of Rheumatology·Dhrubajyoti Sharma, Surjit Singh
Mar 18, 2021·The Journal of International Medical Research·Ji-Yong ZhangGuo-Qing Dong
Jul 17, 1998·Clinical Microbiology Reviews·A H Rowley, S T Shulman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.